dc.contributor.author | Yap, TA | |
dc.contributor.author | Siu, LL | |
dc.contributor.author | Calvo, E | |
dc.contributor.author | Lolkema, MP | |
dc.contributor.author | LoRusso, PM | |
dc.contributor.author | Soria, J-C | |
dc.contributor.author | Plummer, R | |
dc.contributor.author | de Bono, JS | |
dc.contributor.author | Tabernero, J | |
dc.contributor.author | Banerji, U | |
dc.date.accessioned | 2021-03-08T16:02:01Z | |
dc.date.available | 2021-03-08T16:02:01Z | |
dc.date.issued | 2021-02-08 | |
dc.identifier.citation | The Lancet. Oncology, 2021 | |
dc.identifier.issn | 1470-2045 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4401 | |
dc.identifier.eissn | 1474-5488 | |
dc.identifier.doi | 10.1016/s1470-2045(21)00017-6 | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER SCIENCE INC | |
dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
dc.title | SARS-CoV-2 vaccination and phase 1 cancer clinical trials. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2021-01-08 | |
rioxxterms.version | AM | |
rioxxterms.versionofrecord | 10.1016/s1470-2045(21)00017-6 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
rioxxterms.licenseref.startdate | 2021-02-08 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | The Lancet. Oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Pharmacology – Adaptive Therapy | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Pharmacology – Adaptive Therapy | |
pubs.publication-status | Published | |
pubs.embargo.terms | Not known | |
icr.researchteam | Clinical Pharmacology – Adaptive Therapy | |
icr.researchteam | Clinical Pharmacology – Adaptive Therapy | |
dc.contributor.icrauthor | De Bono, Johann | |
dc.contributor.icrauthor | Banerji, Udai | |